Gufic Biosciences to launch Botulinum Neuromedicine in India

Mumbai: Gufic Biosciences Limited ("the Company") recently announced to launch Botulinum Neurotoxin in India in collaboration with USA based Company Prime Bio, Inc., led by Dr Bal Ram Singh. The Company has received regulatory approval to manufacture and market Botulinum Neurotoxin.

The Company is an indigenous manufacturing company to launch such project in India with a robust and inherent world-class infrastructure which will help the Company to bring the cost-effective option of this toxin to India and also expand them to middle east, East and Southeast Asia.

Botulinum Neurotoxin is provided by a kind of bacteria called as clostridium botulinum. Botulinum Neurotoxin is used in therapeutic and aesthetic procedures. Some of the Clinical Uses are Movement Disorders, Spasticity, Pain Syndromes, Cosmetics.

There are a total 137 disorders for which clinical data is available.

Read Also: HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings